Surgery, radiotherapy and chemotherapy are the three pillars of tumor treatment at present, in addition to immunobiological therapy, endocrine therapy, thermotherapy and other adjuvant means also make tumor treatment options diverse. For tumor patients, except for early stage patients who are followed up regularly after surgery, all other patients need to have planned treatment plan before treatment, instead of putting on whatever methods they think of, or putting on all treatments regardless of whether patients need them or not, which not only increases the burden of patients, but also does not benefit tumor treatment. In foreign countries, when a difficult tumor patient is encountered, first of all, the relevant surgeons, medical oncologists, radiologists, pathologists, imaging doctors and pharmacists should get together and discuss together to come up with a reasonable treatment plan, and then treat the patient according to this plan, which is standardized treatment. At the moment, it is very difficult to get together and discuss because our doctors in each department are very busy, but this is exactly what we are trying to do, and we must try to come up with a multidisciplinary plan for the benefit of the patient. Of course, the treatment plan is not unchanged. In the case of chemotherapy, after two courses of chemotherapy, we will definitely judge the patient’s condition and adjust the plan if the effect is not good. Liu Ping, Department of Oncology, The First Affiliated Hospital of Nanjing Medical University In clinical practice, we often see that the treatment effect and toxic side effects of the same treatment regimen for patients suffering from the same kind of cancer are not the same. The main influence of drug treatment effect is the individual difference of tumor, and the individual difference of patients can lead to the difference of toxic and side effects to drugs. Oncologists and researchers are working to find predictors to select the most appropriate drug and dose for each specific patient. Currently, there are already some successes in genetic testing, a genetically guided individualized treatment approach that is now partially used in the clinic to determine the efficacy and the magnitude of toxic side effects of a drug on a patient when certain genes in a tumor (lung, gastrointestinal, breast, etc.) or a patient’s genes are altered. There are more than ten kinds of genes that can be tested, and you can consult with oncologists about this.